Despite having relatively similar pathological endpoints of retinal, cerebral, and cerebellar atrophy, the documented clinical phenotypes, imaging and postmortem studies of CLN1 and CLN3 disease display some strikingly different features in how these diseases progress. The gene discussed is PPT1; the disease is Cerebellar atrophy.